LESCHLY NICK (President and CEO) sold 6.6% of their position (86.87K shares) of 2SEVENTY BIO, INC. on the open market
Open‑market sale worth $254.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/7/2025ACC: 0001562180-25-000245
DirectorOfficer· President and CEO
Since Oct 2021
-86.87K
Net shares
Net seller
$254.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
86.87K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−85.98K
Price / share
$2.94
Trade value
$252.42K
% of position
6.5%
1/3/2025
1.32M→1.23M
Common Stock
Direct
Shares
−892.00
Price / share
$2.78
Trade value
$2.48K
% of position
0.1%
1/6/2025
1.23M→1.23M
Total
Net shares
−86.87K
Net value
-$254.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2025 | S · Sale | −85.98K | $2.94 | $252.42K | 6.5% | 1.32M | 1.23M |
| Common Stock Direct | 1/6/2025 | S · Sale | −892.00 | $2.78 | $2.48K | 0.1% | 1.23M | 1.23M |
| Total | −86.87K | -$254.90K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned15.23K
Common Stock
IndirectShares owned41K
Total
56.23K indirect56.23K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.23K | Indirect |
| Common Stock | 41K | Indirect |
| Total | 56.23K | 56.23K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported